Bengaluru-based Axio Biosolutions has raised $5.2 million in a Series B funding round led by Omidyar Network India along with existing investors Accel, and Chiratae Ventures also participated. The company would deploy the funds towards expanding in the United States and Western Europe along with developing its novel surgical and wound care products for the global market.
Founded in 2008, Axio Biosolutions is a certified medtech developer and manufacturing company focused on Advanced wound care. (Source)
